BLAIR GAULT: Open Payments
NPI 1003395385 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 14 payments from 8 companies in 2025. Trend: 2023 $340 · 2024 $243 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $148 |
| Braeburn Inc. | 3 | $70 |
| Indivior Inc. | 2 | $59 |
| Exact Sciences Corporation | 2 | $30 |
| Astellas Pharma US Inc | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Organon LLC | 1 | $12 |
Products named: CAPLYTA, BRIXADI, SUBLOCADE, The Cologuard Plus Collection Kit, Veozah, VRAYLAR, OTEZLA, NEXPLANON.
Industry payments across SC — which companies pay providers there.
